Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Abaloparatide (Tymlos) Peptide
PTHrP analog for postmenopausal osteoporosis.
What is Abaloparatide (Tymlos)?
Abaloparatide (Tymlos) is a pthrp analog · anabolic bone peptide studied for postmenopausal osteoporosis and male osteoporosis. Below is an educational overview of Abaloparatide (Tymlos) peptide benefits, mechanism, common research protocols, dosage references, and known side effects.
Plain-Language Label Highlights
Brand names: Tymlos
Postmenopausal women with osteoporosis at high fracture risk; men with osteoporosis.
A daily injection (a tweaked PTH-related peptide) that strongly stimulates new bone formation.
Possible osteosarcoma risk in rodents — lifetime use limited to 2 years.
- •Hypercalciuria (calcium in urine)
- •Dizziness
- •Nausea
- •Headache
- •Heart palpitations
- •Orthostatic hypotension
- •High blood/urine calcium
- •Kidney stones
- •Theoretical osteosarcoma risk
- •Prior bone radiation
- •Bone metastases
- •Hypercalcemia
- •Pediatric use
Educational summary of the FDA prescribing information. Not a substitute for the full label or medical advice. Always discuss with a licensed prescriber.
Abaloparatide (Tymlos) Mechanism of Action
Synthetic 34-amino-acid analog of parathyroid hormone-related protein (PTHrP). Selectively activates the PTH1 receptor RG conformation, favoring osteoanabolic effects over resorption.
Abaloparatide (Tymlos) Research Areas & Benefits
Abaloparatide (Tymlos) Dosage & Common Research Protocols
80 mcg SC once daily for up to 2 years.
Protocols summarized for educational reference from published research. Not dosing guidance.
Abaloparatide (Tymlos) Studies & Cited Research
ACTIVE trial
Reduced new vertebral and nonvertebral fractures vs placebo and teriparatide.
Why we trust this source: Published in a peer-reviewed scientific journal with editorial and reviewer oversight.
Citations are linked to PubMed, Google Scholar, and Crossref searches so you can verify the source independently. All references are reviewed during our editorial passes (last reviewed June 1, 2026).
Abaloparatide (Tymlos) Side Effects & Safety Considerations
- •FDA-approved.
- •Orthostatic hypotension possible after dosing.
Explore more peptides
Educational Information Only — Not Medical Advice
All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.
Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.
Ask the Library
Ask anything about peptides — answers come from our curated reference library with citations.